Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Echinococcus multilocularis | Coagulation factor 5 8 type, C terminal | 0.0112 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0018 | 0.0406 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Schistosoma mansoni | dock | 0.0112 | 1 | 1 |
Onchocerca volvulus | 0.0018 | 0.0406 | 0.5 | |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0014 | 0 | 0.5 |
Onchocerca volvulus | 0.0018 | 0.0406 | 0.5 | |
Plasmodium falciparum | LCCL domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0014 | 0 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0018 | 0.0406 | 0.5 |
Toxoplasma gondii | PA14 domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Trypanosoma cruzi | multicopper oxidase, putative | 0.0014 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Plasmodium vivax | LCCL domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Mycobacterium ulcerans | oxidase | 0.0017 | 0.0368 | 0.5 |
Plasmodium vivax | LCCL domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Echinococcus multilocularis | dedicator of cytokinesis protein | 0.0094 | 0.8196 | 0.812 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0018 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Trypanosoma cruzi | multicopper oxidase, putative | 0.0014 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0018 | 0.0406 | 1 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0018 | 0.0406 | 0.5 |
Trypanosoma brucei | multicopper oxidase, putative | 0.0014 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0406 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.